Patent ID: 11970537
Assignee: NANJING GENSCRIPT BIOTECH CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A fusion protein dimer comprising:
a first polypeptide chain comprising a first antibody Fc region, one or more single-domain antibodies fused to the first antibody Fc region, and a first cytokine fused to the first antibody Fc region; and
a second polypeptide chain comprising a second antibody Fc region, one or more single-domain antibodies fused to the second antibody Fc region, and a second cytokine fused to the second antibody Fc region;
wherein the first cytokine is IL-12, and the second cytokine is IL-2 or an IL-2 mutant.